Role of MicroRNAs in Cardiac Preconditioning
- 1 December 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 56 (6) , 581-588
Abstract
Preconditioning (PC) of the heart by sublethal ischemia, mild heat shock, or hypoxia has evolved as a powerful experimental tool to discover novel signaling mechanisms in cardioprotection. The ultimate goal is to determine novel therapeutic targets for potential application in humans to protect the heart against ischemia-related injuries. In recent years, there has been a tremendous interest in understanding the role of small noncoding RNAs, microRNAs (miRs), in cardiovascular diseases. miRs have been recognized as regulators of gene expression by destabilization and translational inhibition of target messenger RNAs. Studies have shown that several miRs, including miR-1, miR-133, miR-21, miR-126, miR-320, miR-92a, and miR-199a, are regulated after preconditioning and play an active role in protecting the heart against ischemia/reperfusion injury. These miRs also drive the synthesis of important cardioprotective proteins including heat shock protein (HSP)-70, endothelial nitric oxide synthase, inducible nitric oxide synthase, HSP-20, Sirt1, and hypoxia-inducible factor 1α. We believe that identification and targeted delivery of miR(s) in the heart could have an immense therapeutic potential in reducing myocardial infarction in patients suffering from heart disease. See Editorial, MicroRNA: Redefining Mechanisms in Cardiovascular Diseases by Maha Abdellatif, Journal of Cardiovascular Pharmacology 2010;56:441-443.Keywords
This publication has 87 references indexed in Scilit:
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Endogenous microRNAs induced by heat‐shock reduce myocardial infarction following ischemia–reperfusion in miceFEBS Letters, 2008
- miR-126 Regulates Angiogenic Signaling and Vascular IntegrityDevelopmental Cell, 2008
- The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and AngiogenesisDevelopmental Cell, 2008
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- The late phase of preconditioning and its natural clinical application—gene therapyHeart Failure Reviews, 2007
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007
- The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2Nature Medicine, 2007
- A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failureProceedings of the National Academy of Sciences, 2006
- Myogenic factors that regulate expression of muscle-specific microRNAsProceedings of the National Academy of Sciences, 2006